Techniques in Vascular & Interventional Radiology
Volume 10, Issue 2 , Pages 149-158 , June 2007

Percutaneous Image-Guided Prostate Cancer Treatment: Cryoablation as a Successful Example

  • Gary Onik, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Gary Onik, MD, Division of Surgical Imaging, Center for Surgical Advancement, Department of Surgery and Urology, Celebration Health, Celebration, FL 34747.

References 

  1. Health Care Financing Administration. Medicare Coverage Policy: Decisions. Bagley GP. Cryoablation ablation of the prostate (#CAG-00031) http://www.hcfa.gov/coverage/8b3-f1.htmaccessed November 7, 2001
  2. George N. Therapeutic dilemmas in prostate cancer: justification for watchful waiting. Eur Urol. 1998;34(suppl 3):33–36
  3. Villers A, McNeal JE, Freiha FS, et al. Multiple cancers in the prostate (Morphologic features of clinically recognized vs incidental tumors). Cancer. 1992;70:2313–2318
  4. Gondor MJ, Soanes WA, Shulman S. Cryosurgical treatment of the prostate. Invest Urol. 1966;3:372–378
  5. Bonney WW, Fallon B, Gerber WL, et al. Cryosurgery in prostatic cancer: survival. Urology. 1982;19:37–42
  6. Onik GM, Cohen JK, Reyes GD, et al. Trans-rectal ultrasound guided percutaneous radical cryosurgical ablation of the prostate. Cancer. 1993;72:1291–1299
  7. Pisters LL, von Eschenbach AC, Scott SM, et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997;157:921–925
  8. Wong WS, Chinn DO, Chinn M, et al. Cryoablation as a treatment for prostate carcinoma: results and complications. Cancer. 1997;79:963–974
  9. Cespedes RD, Pisters LL, von Eschenbach AC, et al. Long-term followup of incontinence and obstruction after salvage cryosurgical ablation of the prostate: results in 143 patients. J Urol. 1997;157:237–240
  10. Katz AE, Rewcastle JC. The current and potential role of cryoablation as a primary treatment for prostate cancer. Curr Oncol Rep. 2003;5:231–238
  11. Gould RS. Total cryoablation of the prostate versus standard cryoablation versus radical prostatectomy: comparison of early results and the role of trans-urethral resection in cryoablation. J Urol. 1999;162:1653–1657
  12. Donnelly B, Salikan J: Prospective randomized study comparing cryoablation and external beam radiation therapy. Presented at the AUA annual meeting. Anaheim, CA, 5/07
  13. Onik G, Cooper C, Goldberg HI, et al. Ultrasonic characteristics of frozen liver. Cryobiology. 1984;21:321–328
  14. Onik G, Rubinsky B, Zemel R, et al. Ultrasound-guided hepatic cryoablation in the treatment of metastatic colon carcinoma: preliminary results. Cancer. 1991;67:901–907
  15. Ravikumar TS, Kane I, Cady B, et al. A 5-year study of cryoablation in the treatment of liver tumors. Arch Surg. 1991;126:1520–1524
  16. Steele G. Cryoablation in hepatic surgery. Semin Liver Dis. 1994;14:120–125
  17. Vaidya A, Hawke C, Tiguert R, et al. Intraoperative T staging in radical retropubic prostatectomy: is it reliable?. Urology. 2001;57:949–954
  18. Partin AW, Yoo J, Carter HB, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1993;150:110–114
  19. Tewari A, Narayan P. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks. J Urol. 1998;160:430–436
  20. Eggleston JC, Walsh PC. Radical prostatectomy with preservation of sexual function: pathological findings in the first 100 cases. J Urol. 1985;134:1146–1148
  21. Connolly JA, Shinohara K, Carroll P. Cryoablation for locally advanced (T3) prostate cancer. Semin Urol Oncol. 1997;15:244–249
  22. Miller RJ, Cohen JK, Merlotti LA, et al. Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate. Urology. 1994;44:170–174
  23. Onik G, Narayan P, Brunelle R, et al. Saline injection into Denonvilliers’ fascia during prostate cryoablation. J Min Ther Relat Tech. 2000;9:423–427
  24. Bahn DK, Lee F, Bandalament R, et al. 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60(2 suppl 1):3–11
  25. Pilepich MV, Winter K, John MJ, et al. Phase III radiation therapy oncology group(RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 2001;50:1243–1252
  26. Lawton CA, Winter K, Murray K, et al. Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 2001;49:937–946
  27. Santiago RJ, Wu L, Harris E, et al. Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 2004;58:233–240
  28. Onik G, Narayan P, Vaughan D, et al. Focal nerve sparing cryoablation for the treatment of primary prostate cancer: A new approach to preserving potency. Urology. 2002;60:109–114
  29. Onik G, Vaughan D, Lotenfoe R, et al: The “male lumpectomy”: focal therapy for prostate cancer using cryoablation. Urology, in press
  30. Djavan B, Susani M, Bursa B, et al. Predictability and significance of multi-focal prostate cancer in the radical prostatectomy specimen. Tech Urol. 1999;5:139–142
  31. Villers A, McNeal JE, Freiha FS, et al. Multiple cancers in the prostate (Morphologic features of clinically recognized vs. incidental tumors). Cancer. 1992;70:2312–2318
  32. Rukstalis DB, Goldknopf JL, Crowley EM, et al. Prostate cryoablation: A scientific rationale for future modifications. Urology. 2002;60(2 suppl 1):19–25
  33. Noguchi M, Stamey TA, McNeal JE, et al. Prognostic factors for multi-focal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol. 2003;170:459–463
  34. Crawford ED, Wilson SS, Torkko KC, et al. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy. BJU Int. 2005;96:999–1004
  35. Onik GM. 3D global mapping biopsies (A more efficacious method of determining the extent of prostate cancer). Presented at Consensus Conference on Focal Therapy of Prostate Cancer. Orlando, Florida, February 24 2006;
  36. Neerhut GJ, Wheeler T, Cantini M, et al. Salvage radical prostatectomy for radiorecurrent adenocarcinoma of the prostate. J Urol. 1988;140:544–549
  37. Rainwater LM, Zincke H. Radical prostatectomy after radiation therapy for cancer of the prostate: feasibility and prognosis. J Urol. 1988;140:1455–1459
  38. Bales GT, Williams MJ, Sinner M, et al. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology. 1995;46:676–680
  39. de la Taille A, Hayek O, Benson MC, et al. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Urology. 2000;55:79–84
  40. Tatsutani K, Rubinsky B, Onik G, et al. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology. 1996;48:441–447
  41. Moore Y, Sofer P. Successful treatment of locally confined prostate cancer with the seed net system: preliminary multi-center results (Clinical Application Notes Feb 2001). http://Galilmedical.com(accessed November 7, 2001)

PII: S1089-2516(07)00083-2

doi: 10.1053/j.tvir.2007.09.007

Techniques in Vascular & Interventional Radiology
Volume 10, Issue 2 , Pages 149-158 , June 2007

Article Tools

* Image Usage & Resolution